Get started
MMM

MICROBA LIFE SCIENCES LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

MAP chart


Full chart

MAP upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪76.13 M‬AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.050AUD
Net income (FY)
‪−19.94 M‬AUD
Revenue (FY)
‪12.09 M‬AUD
Shares float
‪246.31 M‬
Beta (1Y)
−1.16

About MICROBA LIFE SCIENCES LIMITED


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Luke Reid
Website
microba.com
Headquarters
Brisbane
Founded
2017
ISIN
AU0000209868
FIGI
BBG015D3N4T1
Microba Life Sciences Ltd. analyzes the microbiome to discover novel therapeutics and develop new diagnostic tools. Its therapeutic discovery platform,analysis platform and discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The firm offers microbiome testing services via distribution partners, and is working on microbial cell therapies for inflammatory bowel disease, cancer immunotherapy and autoimmune disease. The company was founded by Gene Tyson and Philip Hugenholtz in 2017 and is headquartered in Brisbane, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

MAP news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MAP is 0.170 AUD — it hasn't changed in the past 24 hours. Watch MICROBA LIFE SCIENCES LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MICROBA LIFE SCIENCES LIMITED stocks are traded under the ticker MAP.
MAP stock has risen by 6.25% compared to the previous week, the month change is a −5.56% fall, over the last year MICROBA LIFE SCIENCES LIMITED has showed a −26.09% decrease.
We've gathered analysts' opinions on MICROBA LIFE SCIENCES LIMITED future price: according to them, MAP price has a max estimate of 0.44 AUD and a min estimate of 0.33 AUD. Watch MAP chart and read a more detailed MICROBA LIFE SCIENCES LIMITED stock forecast: see what analysts think of MICROBA LIFE SCIENCES LIMITED and suggest that you do with its stocks.
MAP reached its all-time high on Aug 4, 2023 with the price of 0.425 AUD, and its all-time low was 0.125 AUD and was reached on Oct 13, 2022. View more price dynamics on MAP chart.
See other stocks reaching their highest and lowest prices.
MAP stock is 0.00% volatile and has beta coefficient of −1.16. Track MICROBA LIFE SCIENCES LIMITED stock price on the chart and check out the list of the most volatile stocks — is MICROBA LIFE SCIENCES LIMITED there?
Today MICROBA LIFE SCIENCES LIMITED has the market capitalization of ‪76.13 M‬, it has increased by 9.09% over the last week.
Yes, you can track MICROBA LIFE SCIENCES LIMITED financials in yearly and quarterly reports right on TradingView.
MICROBA LIFE SCIENCES LIMITED is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
MICROBA LIFE SCIENCES LIMITED revenue for the last half-year amounts to ‪8.80 M‬ AUD, despite the estimated figure of ‪8.50 M‬ AUD. In the next half-year revenue is expected to reach ‪8.10 M‬ AUD.
MAP net income for the last half-year is ‪−8.45 M‬ AUD, while the previous report showed ‪−11.49 M‬ AUD of net income which accounts for 26.44% change. Track more MICROBA LIFE SCIENCES LIMITED financial stats to get the full picture.
No, MAP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MICROBA LIFE SCIENCES LIMITED EBITDA is ‪−23.92 M‬ AUD, and current EBITDA margin is −197.86%. See more stats in MICROBA LIFE SCIENCES LIMITED financial statements.
Like other stocks, MAP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MICROBA LIFE SCIENCES LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MICROBA LIFE SCIENCES LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MICROBA LIFE SCIENCES LIMITED stock shows the strong sell signal. See more of MICROBA LIFE SCIENCES LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.